A double-blinded, randomised, two-period crossover Euglycemic Clamp Trial investigating the pharmacokinetics, glucodynamics and safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog) in subjects with type 1 diabetes
Latest Information Update: 07 Jun 2017
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Adocia
- 16 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 02 Sep 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 15 Jan 2014 New trial record